CareDx (CDNA) Preferred Stock Liabilities (2013 - 2014)
CareDx (CDNA) posted Preferred Stock Liabilities of $149.4 million for Q2 2014, up 10.53% sequentially from $135.2 million in Q4 2013.
CareDx (CDNA) Preferred Stock Liabilities (2013 - 2014) Analysis & Trends
CareDx has reported Preferred Stock Liabilities for 2 years, with the latest figure at $149.4 million in Q2 2014.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $149.4 million in Q2 2014, while the trailing twelve-month figure through Jun 2014 was $149.4 million (changed N/A YoY) and the FY2013 annual result came in at $135.2 million, changed N/A from the prior year.
- Preferred Stock Liabilities improved to $149.4 million in Q2 2014 per CDNA's latest filing, from $135.2 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $149.4 million in Q2 2014 and troughed at $135.2 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | CareDx | 2.35 Bn | 1.98 Bn | 116.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 808,000.00 |
| Dec 31, 2013 | 525,000.00 |